Cargando…

Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis

Psoriasis is a chronic, inflammatory, often relapsing disease that is frequently associated with other diseases of similar pathogenesis. The multi-morbidity in the psoriasis population significantly impedes both diagnosis and implementation of appropriate preventive measures. However, the common den...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olszewski, Robert, Ćwiklińska, Klaudia, Maślińska, Maria, Kwiatkowska, Brygida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494789/ https://www.ncbi.nlm.nih.gov/pubmed/36186830 http://dx.doi.org/10.5114/reum.2022.119043

Ejemplares similares

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system – the case of Poland
por: Raciborski, Filip, et al.
Publicado: (2016)

Factors of depression among patients with rheumatoid arthritis
por: Kwiatkowska, Brygida, et al.
Publicado: (2018)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

Diagnostic imaging of psoriatic arthritis. Part I: etiopathogenesis, classifications and radiographic features
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2016)

Macrolide Therapy in Chronic Inflammatory Diseases
por: Kwiatkowska, Brygida, et al.
Publicado: (2012)

The place of omega-3 and omega-6 acids in supplementary treatment of inflammatory joint diseases
por: Kwiatkowska, Brygida, et al.
Publicado: (2020)

Trends in psoriatic arthritis epidemiology in Poland
por: Tłustochowicz, Małgorzata, et al.
Publicado: (2020)

From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
por: Lebwohl, Mark G., et al.
Publicado: (2015)

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study
por: Kurowska, Weronika, et al.
Publicado: (2018)

Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome – a preliminary study
por: Maślińska, Maria, et al.
Publicado: (2016)

Risk factors and predictors of psoriatic arthritis in patients with psoriasis
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2013)

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2022)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
por: Kristensen, Lars E., et al.
Publicado: (2023)

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis
por: Li, Lin, et al.
Publicado: (2015)

Cardiovascular Risk in Patients with Psoriatic Arthritis
por: Zhu, Tracy Y., et al.
Publicado: (2012)

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients
por: Patrick, Matthew T., et al.
Publicado: (2018)

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis
por: Loft, Nikolai Dyrberg, et al.
Publicado: (2018)

The prevalence of ANA antibodies, anticentromere antibodies, and anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren’s syndrome compared to patients with dryness symptoms without primary Sjögren’s syndrome confirmation
por: Maślińska, Maria, et al.
Publicado: (2017)

Sleep disorders in patients with psoriatic arthritis and psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2020)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Qi, Fei, et al.
Publicado: (2021)

The burden of psoriasis in patients with early psoriatic arthritis
por: Kasiem, Fazira R, et al.
Publicado: (2021)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
por: Panda, Saumya
Publicado: (2022)

Association of Behçet disease with psoriasis and psoriatic arthritis
por: Hahn, Hyung Jin, et al.
Publicado: (2021)

Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire
por: You, Hyang-Suk, et al.
Publicado: (2015)

Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
por: Butbul Aviel, Yonatan, et al.
Publicado: (2013)

The association between biologic agents and the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A protocol for a systematic review and meta-analysis
por: Ma, Jie, et al.
Publicado: (2019)

Sjögren’s syndrome: still not fully understood disease
por: Maślińska, Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o71g3tv4ntto3hhp3s33t50mv8